Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
Acorda Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Acorda Therapeutics reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, six executives at Acorda Therapeutics received on average a compensation package of $1.4M, a 6% decrease compared to previous year.
Average pay of disclosed executives at Acorda Therapeutics
Ron Cohen, Chief Executive Officer, received $2.4M in total, which increased by 20% compared to 2017. 67% of Cohen's compensation, or $1.6M, was in non-equity incentive plan. Cohen also received $796K in salary and $8.3K in other compensation.
For fiscal year 2018, the median employee pay was $202,725 at Acorda Therapeutics. Therefore, the ratio of Ron Cohen's pay to the median employee pay was 12 to one.
Jane Wasman, General Counsel, received a compensation package of $1.4M, which increased by 15% compared to previous year. 60% of the compensation package, or $864K, was in non-equity incentive plan.
Burkhard Blank, Chief Medical Officer, earned $1.3M in 2018, a 9% decrease compared to previous year.
Andrew Hindman, Chief Business Officer, received $1.2M in 2018, which decreases by 28% compared to 2017.
Lauren Sabella, Chief Commercial Officer, earned $1M in 2018, a 31% decrease compared to previous year.
David Lawrence, Chief, Business Operations and Principal Accounting Officer, received $973K in 2018, which decreases by 3% compared to 2017.
Related executives
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
David Lawrence
Acorda Therapeutics
Former Chief, Business Operations and Principal Accounting Officer
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
Andrew Hindman
Acorda Therapeutics
Chief Business Officer
Jane Wasman
Acorda Therapeutics
General Counsel
Lauren Sabella
Acorda Therapeutics
Chief Operating Officer
You may also like
Source: SEC filing on April 26, 2019.